The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of pembrolizumab (P) in patients (pts) with previously-treated mesothelioma (MM).
 
Arpita Desai
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Buerkley Rose
No Relationships to Disclose
 
Erika Pemberton
No Relationships to Disclose
 
Bianca Hill
No Relationships to Disclose
 
Christopher M. Straus
No Relationships to Disclose
 
Yi-Hung Carol Tan
No Relationships to Disclose
 
Tanguy Y. Seiwert
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Innate Pharma; Jounce Therapeutics; Lilly; Merck; Merck Serono
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)
 
Hedy L. Kindler
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; ERYTECH Pharma; Five Prime Therapeutics; GlaxoSmithKline; ipsen; MedImmune; Merck; Paradox Therapeutics
Research Funding - Aduro Biotech; AstraZeneca; Bayer; Bristol-Myers Squibb; Deciphera; GlaxoSmithKline; Lilly; MedImmune; Merck; Polaris; Verastem